• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺导管原位癌(DCIS)中的多蛋白空间特征。

Multi-protein spatial signatures in ductal carcinoma in situ (DCIS) of breast.

机构信息

Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.

GE Research, Niskayuna, NY, 12309, USA.

出版信息

Br J Cancer. 2021 Mar;124(6):1150-1159. doi: 10.1038/s41416-020-01216-6. Epub 2021 Jan 7.

DOI:10.1038/s41416-020-01216-6
PMID:33414541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7961015/
Abstract

BACKGROUND

There is limited knowledge about DCIS cellular composition and relationship with breast cancer events (BCE).

METHODS

Immunofluorescence multiplexing (MxIF) was used to image and quantify 32 cellular biomarkers in FFPE DCIS tissue microarrays. Over 75,000 DCIS cells from 51 patients (median 9 years follow-up for non-BCE cases) were analysed for profiles predictive of BCE. K-means clustering was used to evaluate cellular co-expression of epithelial markers with ER and HER2.

RESULTS

Only ER, PR and HER2 significantly correlated with BCE. Cluster analysis identified 6 distinct cell groups with different levels of ER, Her2, cMET and SLC7A5. Clusters 1 and 3 were not significant. Clusters 2 and 4 (high ER/low HER2 and SLC7A5/mixed cMET) significantly correlated with low BCE risk (P = 0.001 and P = 0.034), while cluster 6 (high HER2/low ER, cMET and SLC7A5) correlated with increased risk (P = 0.018). Cluster 5 (similar to cluster 6, except high SLC7A5) trended towards significance (P = 0.072). A continuous expression score (Escore) based on these 4 clusters predicted likelihood of BCE (AUC = 0.79, log-rank test P = 5E-05; LOOCV AUC = 0.74, log-rank test P = 0.006).

CONCLUSION

Multiplexed spatial analysis of limited tissue is a novel method for biomarker analysis and predicting BCEs. Further validation of Escore is needed in a larger cohort.

摘要

背景

关于 DCIS 细胞组成及其与乳腺癌事件 (BCE) 的关系,目前人们的了解有限。

方法

使用免疫荧光多重检测(MxIF)对 FFPE DCIS 组织微阵列中的 32 种细胞生物标志物进行成像和定量分析。对 51 例患者(非 BCE 病例的中位随访时间为 9 年)的超过 75000 个 DCIS 细胞进行分析,以确定预测 BCE 的特征。采用 K 均值聚类法评估 ER 和 HER2 与上皮标志物的细胞共表达情况。

结果

仅 ER、PR 和 HER2 与 BCE 显著相关。聚类分析确定了 6 个不同的细胞群,其 ER、Her2、cMET 和 SLC7A5 水平不同。群 1 和 3 没有统计学意义。群 2 和 4(高 ER/低 HER2 和 SLC7A5/混合 cMET)与低 BCE 风险显著相关(P=0.001 和 P=0.034),而群 6(高 HER2/低 ER、cMET 和 SLC7A5)与风险增加相关(P=0.018)。群 5(与群 6 相似,除了 SLC7A5 较高)呈显著趋势(P=0.072)。基于这 4 个群的连续表达评分(Escore)预测 BCE 的可能性(AUC=0.79,对数秩检验 P=5E-05;LOOCV AUC=0.74,对数秩检验 P=0.006)。

结论

对有限组织进行的多重空间分析是一种新的生物标志物分析和预测 BCE 的方法。需要在更大的队列中进一步验证 Escore。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/7961015/94c704609c80/41416_2020_1216_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/7961015/ec98b8c767cd/41416_2020_1216_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/7961015/d44466fe5776/41416_2020_1216_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/7961015/e541ff37c079/41416_2020_1216_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/7961015/39a63c78bb13/41416_2020_1216_Fig4a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/7961015/94c704609c80/41416_2020_1216_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/7961015/ec98b8c767cd/41416_2020_1216_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/7961015/d44466fe5776/41416_2020_1216_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/7961015/e541ff37c079/41416_2020_1216_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/7961015/39a63c78bb13/41416_2020_1216_Fig4a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/7961015/94c704609c80/41416_2020_1216_Fig5_HTML.jpg

相似文献

1
Multi-protein spatial signatures in ductal carcinoma in situ (DCIS) of breast.乳腺导管原位癌(DCIS)中的多蛋白空间特征。
Br J Cancer. 2021 Mar;124(6):1150-1159. doi: 10.1038/s41416-020-01216-6. Epub 2021 Jan 7.
2
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.人表皮生长因子受体 2 阳性导管原位癌患者后续原位和浸润性乳腺癌的风险。
Ann Oncol. 2015 Apr;26(4):682-687. doi: 10.1093/annonc/mdv013. Epub 2015 Jan 18.
3
Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran.男性乳腺癌:来自伊朗克尔曼沙阿省放射肿瘤学系的报告。
Asian Pac J Cancer Prev. 2016;17(5):2593-6.
4
Evaluating the Risk of Upstaging HER2-Positive DCIS to Invasive Breast Cancer.评估 HER2 阳性 DCIS 升级为浸润性乳腺癌的风险。
Ann Surg Oncol. 2017 Oct;24(10):2999-3003. doi: 10.1245/s10434-017-5941-0. Epub 2017 Aug 1.
5
Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events.原发性导管原位癌(DCIS)与相应局部病变之间乳腺癌受体的克隆性改变。
Eur J Cancer. 2014 Feb;50(3):517-24. doi: 10.1016/j.ejca.2013.10.020. Epub 2013 Nov 22.
6
Is there a low-grade precursor pathway in breast cancer?乳腺癌是否存在低度恶性前体途径?
Ann Surg Oncol. 2012 Apr;19(4):1115-21. doi: 10.1245/s10434-011-2053-0. Epub 2011 Sep 21.
7
Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.基于ERBB2状态的乳腺导管原位癌中的差异基因表达
Cancer Control. 2017 Jan;24(1):102-110. doi: 10.1177/107327481702400117.
8
The Relationships between HER2 Overexpression and DCIS Characteristics.人表皮生长因子受体2(HER2)过表达与导管原位癌特征之间的关系
Breast J. 2017 May;23(3):307-314. doi: 10.1111/tbj.12735. Epub 2016 Dec 10.
9
[Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].[脂肪酸合酶在乳腺浸润性导管癌中的表达及其与HER2的关系]
Zhonghua Bing Li Xue Za Zhi. 2013 Apr;42(4):257-61. doi: 10.3760/cma.j.issn.0529-5807.2013.04.010.
10
The target for statins, HMG-CoA reductase, is expressed in ductal carcinoma-in situ and may predict patient response to radiotherapy.他汀类药物的靶点HMG-CoA还原酶在导管原位癌中表达,可能预测患者对放疗的反应。
Ann Surg Oncol. 2014 Sep;21(9):2911-9. doi: 10.1245/s10434-014-3708-4. Epub 2014 Apr 29.

引用本文的文献

1
DCIS Progression and the Tumor Microenvironment: Molecular Insights and Prognostic Challenges.导管原位癌进展与肿瘤微环境:分子见解与预后挑战
Cancers (Basel). 2025 Jun 10;17(12):1925. doi: 10.3390/cancers17121925.
2
Clinical Proteomics Reveals Vulnerabilities in Noninvasive Breast Ductal Carcinoma and Drives Personalized Treatment Strategies.临床蛋白质组学揭示非侵袭性乳腺导管癌的脆弱性并推动个性化治疗策略
Cancer Res Commun. 2025 Jan 1;5(1):138-149. doi: 10.1158/2767-9764.CRC-24-0287.
3
Hyperactivation of mTOR/eIF4E Signaling Pathway Promotes the Production of Tryptophan-To-Phenylalanine Substitutants in EBV-Positive Gastric Cancer.

本文引用的文献

1
Loss of constitutive expression in breast cancer associated with worse prognosis.乳腺癌中组成型表达的缺失与更差的预后相关。
Breast Cancer (Dove Med Press). 2017 Jun 10;9:415-428. doi: 10.2147/BCTT.S131284. eCollection 2017.
mTOR/eIF4E 信号通路的过度激活促进 EBV 阳性胃癌中色氨酸到苯丙氨酸取代物的产生。
Adv Sci (Weinh). 2024 Sep;11(35):e2402284. doi: 10.1002/advs.202402284. Epub 2024 Jul 12.
4
Companion diagnostic requirements for spatial biology using multiplex immunofluorescence and multispectral imaging.使用多重免疫荧光和多光谱成像进行空间生物学研究的伴随诊断要求。
Front Mol Biosci. 2023 Feb 9;10:1051491. doi: 10.3389/fmolb.2023.1051491. eCollection 2023.
5
Overexpression of Estrogen Receptor α in Mammary Glands of Aging Mice Is Associated with a Proliferative Risk Signature and Generation of Estrogen Receptor α-Positive Mammary Adenocarcinomas.衰老小鼠乳腺中雌激素受体 α 的过表达与增殖风险特征相关,并产生雌激素受体 α 阳性乳腺腺癌。
Am J Pathol. 2023 Jan;193(1):103-120. doi: 10.1016/j.ajpath.2022.09.008. Epub 2022 Dec 1.
6
Next-Generation Pathology Using Multiplexed Immunohistochemistry: Mapping Tissue Architecture at Single-Cell Level.使用多重免疫组织化学的新一代病理学:在单细胞水平绘制组织结构图
Front Oncol. 2022 Jul 29;12:918900. doi: 10.3389/fonc.2022.918900. eCollection 2022.
7
Ductal Carcinoma In Situ of Breast: From Molecular Etiology to Therapeutic Management.乳腺导管原位癌:从分子发病机制到治疗管理。
Endocrinology. 2022 Apr 1;163(4). doi: 10.1210/endocr/bqac027.